Author:
Kenanoglu Sercan,Akalin Hilal,Aslan Dicle,Inanc Mevlude,Ozturk Figen,Dundar Munis
Reference78 articles.
1. PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy;Alhesa;Int. J. Immunopathol. Pharmacol.,2022
2. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer;Atchley;J. Clin. Oncol.,2008
3. Sacituzumab Govitecan in metastatic triple-negative breast Cancer;Bardia;New England Journal of Medicine,2021
4. Triple-negative breast cancer: recent treatment advances [version 1; peer review: 2 approved];Bergin;F1000Research,2019
5. Bio USA, T. (n.d.).Mir-X™ miRNA First-Strand Synthesis and TB Green® qRT-PCR User Manual Mir-X miRNA First-Strand Synthesis and TB Green qRT-PCR User Manual. https://www.takarabio.com/documents/User Manual/Mir/Mir-X miRNA First-Strand Synthesis and TB Green qRT-PCR User Manual.pdf.